Source:http://linkedlifedata.com/resource/pubmed/id/15819813
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2005-4-11
|
pubmed:abstractText |
The effects of pancreas transplantation (PTx) on diabetic retinopathy (DR) are still debated. We studied the course of DR in 48 patients (age: 40 +/- 7 years; males/females 26/22, body mass index (BMI): 23.0 +/- 2.4 kg/m2, duration of diabetes: 24 +/- 8 years) bearing a successful PTx (combined with a kidney). Follow-up ranged 6-60 months (median: 17 months). Before transplantation, according to the Eurodiab Study classification, 12 patients (25%) had nonproliferative retinopathy (NPDR; mild, moderate or severe), and 36 patients (75%) had laser-treated and/or proliferative retinopathy (LT/PDR). During the follow-up, in the NPDR group improvement/deterioration was defined as regression/progression to a lower/higher retinopathy grade; in the LT/PTD group, stabilization was defined as no new neo-vessel formation or development of new lesions requiring laser-treatment. In the NPDR group, five (41.7%) patients improved of one or more lesion grading, three (25%) patients showed no change, and four (33.3%) patients progressed of one grade. In the LT/PDR group, the post-transplant data were: stabilization in 35 (97%) patients, and worsening in one (3%) patient. The number of improved/stabilized patients was significantly higher in the transplanted than in a control group of nontransplanted type 1 diabetic patients. In conclusion, despite a relatively short follow-up period, successful PTx in our cohort of patients was associated with improvement and/or stabilization of DR in the majority of recipients.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0934-0874
|
pubmed:author |
pubmed-author:AragonaMicheleM,
pubmed-author:BoggiUgoU,
pubmed-author:CoppelliAlbertoA,
pubmed-author:Del PratoStefanoS,
pubmed-author:GiannarelliRosaR,
pubmed-author:MarchettiPieroP,
pubmed-author:MoscaFrancoF,
pubmed-author:RizzoGaetanoG,
pubmed-author:SartiniMariasoleM,
pubmed-author:VistoliFabioF
|
pubmed:issnType |
Print
|
pubmed:volume |
18
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
619-22
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15819813-Adult,
pubmed-meshheading:15819813-Blood Glucose,
pubmed-meshheading:15819813-Cohort Studies,
pubmed-meshheading:15819813-Diabetes Mellitus, Type 1,
pubmed-meshheading:15819813-Diabetic Nephropathies,
pubmed-meshheading:15819813-Diabetic Retinopathy,
pubmed-meshheading:15819813-Female,
pubmed-meshheading:15819813-Hemoglobin A, Glycosylated,
pubmed-meshheading:15819813-Humans,
pubmed-meshheading:15819813-Islets of Langerhans Transplantation,
pubmed-meshheading:15819813-Kidney Transplantation,
pubmed-meshheading:15819813-Male,
pubmed-meshheading:15819813-Middle Aged
|
pubmed:year |
2005
|
pubmed:articleTitle |
Effects of pancreas-kidney transplantation on diabetic retinopathy.
|
pubmed:affiliation |
Department of Endocrinology and Metabolism-Metabolic Unit, University of Pisa, I-56121, Pisa, Italy.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial,
Research Support, Non-U.S. Gov't
|